SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
China NMPA approves Sanofi’s Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome: Paris Saturday, January 17, 2026, 11:00 Hrs ...
Egypt and Sudan welcomed on Saturday President Donald Trump’s offer to resume U.S. mediation efforts with Ethiopia to resolve a ...
Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...
Alcohol can interact dangerously with common medications and supplements. Learn which combinations to avoid and how to reduce ...
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...